Consequences of Clinical Sequencing 2011

Currently, the rate of technological advancements for next-generation sequencing (NGS) platforms is projected to drop sequencing costs below the $1,000 level. Thus, as more individuals have the ability to sequence their genome, the question becomes what is done with the information? While the scientific community has largely accepted the utility of sequencing for research purposes, the use of the technology in a clinical setting has yet to be fully addressed or accepted by the medical community. Bridging the gap between research and medicine by forming collaborations will not only demonstrate the clinical utility of sequencing, but also pave the way for how this technology can potentially be used by a new class of physicians and their patients.